These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11113836)

  • 1. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of omeprazole use in the treatment of acid-related disorders in children.
    Zimmermann AE; Walters JK; Katona BG; Souney PE; Levine D
    Clin Ther; 2001 May; 23(5):660-79; discussion 645. PubMed ID: 11394727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
    Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole for severe reflux esophagitis in children.
    De Giacomo C; Bawa P; Franceschi M; Luinetti O; Fiocca R
    J Pediatr Gastroenterol Nutr; 1997 May; 24(5):528-32. PubMed ID: 9161946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole: therapy of choice in intellectually disabled children.
    Böhmer CJ; Niezen-de Boer RC; Klinkenberg-Knol EC; Meuwissen SG
    Arch Pediatr Adolesc Med; 1998 Nov; 152(11):1113-8. PubMed ID: 9811290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
    Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Liedman B; Hatlebakk JG; Julkonen R; Levander K; Carlsson J; Lamm M; Wiklund I
    J Am Coll Surg; 2001 Feb; 192(2):172-9; discussion 179-81. PubMed ID: 11220717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group.
    Thjodleifsson B; Beker JA; Dekkers C; Bjaaland T; Finnegan V; Humphries TJ
    Dig Dis Sci; 2000 May; 45(5):845-53. PubMed ID: 10795744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
    Hassall E; Shepherd R; Koletzko S; Radke M; Henderson C; Lundborg P
    Aliment Pharmacol Ther; 2012 Feb; 35(3):368-79. PubMed ID: 22176465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis.
    Zendehdel N; Biramijamal F; Hossein-Nezhad A; Zendehdel N; Sarie H; Doughaiemoghaddam M; Pourshams A
    Arch Iran Med; 2010 Sep; 13(5):406-12. PubMed ID: 20804307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis.
    Lightdale CJ; Schmitt C; Hwang C; Hamelin B
    Dig Dis Sci; 2006 May; 51(5):852-7. PubMed ID: 16773434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
    Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
    J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omeprazole on the course of associated esophagitis and laryngitis.
    Jaspersen D; Weber R; Hammar CH; Draf W
    J Gastroenterol; 1996 Dec; 31(6):765-7. PubMed ID: 9027637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.